Friday, September 24, 2021

Pharma packaging manufacturer invests in new facilities to produce COVID test components

A Hull firm that specialises in designing and manufacturing pharmaceutical packaging is producing millions of components used in Covid-19 PCR tests after investing £12 million in new facilities, with support from Lloyds Bank.

Origin Pharma Packaging, based in Melton, relocated its distribution depot to a new site in Scunthorpe and redeveloped the vacated space at its headquarters to create a new facility for filling the vials used in sample collection kits.

The investment gives Origin a new string to its bow, supporting its ambition to double turnover within three years.

The facility, which is highly automated and completely sterile, can fill up to 140 million vials per year.

It is anticipated that, in future, it will be used to supply Covid-19 vaccines and other drugs.

Managing Director, Keith Wade, said: “Demand for sample collection kits meant that we had to flex very quickly and get this facility up and running within months. It is one of the leading facilities of its kind in the country and a big asset for the business. We felt obliged to be part of the fight against the pandemic, both at home and around the world.

“It’s a versatile site, opening up new opportunities for us to work alongside new partners, and creating highly-skilled jobs. We’ve never stopped investing, but this will take us to the next level.”

The family-owned business, which also has offices in Glasgow, Manchester, London and Sydney, specialises in producing medicine bottles for liquids and tablets and is a leading supplier to UK pharmacists.

Turnover has grown from £10 million in 2015 to more than £20 million in 2020, and Origin is targeting revenues of £40 million by the end of 2023.

Around 30% of revenues currently come from exports, and the company is pursuing growth opportunities in Europe, including in the medicinal cannabis sector and cosmetics industry.

It is also developing a new line of interactive packaging that will help record data in clinical trials of new drugs, making the process faster and more accurate.

Natalie Hancock, relationship director at Lloyds Bank, said: “Origin has risen to the challenge of the coronavirus pandemic and is an essential supplier of tests to countries around the world.

“This investment means that, as well as designing and manufacturing pharmaceutical packaging to the highest standards, by branching out into component production Origin can now provide a complete solution for its customers.

“Origin is a fantastic example of an innovative, entrepreneurial and highly ambitious Yorkshire business that is making a difference in the world as well as achieving commercial success.”

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemichaving a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £31.50 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.

Latest news

Related news

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.